Discover trends, market shifts, and competitive outlooks for the type 2 diabetes industry through 2025-2034 with The Business Research Company’s reliable data and in-depth research

What Is the Current and Projected Market Size of the Type 2 Diabetes Market Through 2034?

Growth has been robust in recent years for the type 2 diabetes market. The industry is projected to expand from $48.14 billion in 2024 to $51.96 billion in 2025, boasting a compound annual growth rate (CAGR) of 7.9%. Key drivers of this growth during the historical period include lifestyle and dietary modifications, an aging demography, advancements in pharmaceuticals, and public health campaigns.

Forecasts show robust expansion in the type 2 diabetes market in the upcoming years. The market size is projected to escalate to $72.22 billion by 2029, at a compound annual growth rate (CAGR) of 8.6%. Factors contributing to this projected growth during the forecast period can be traced back to the worldwide diabetes outbreak, personalized healthcare, technological progress, and alterations in healthcare policies. Other trends predicted to shape this period include the rise of digital health and telemedicine, increased emphasis on prevention and early intervention, artificial intelligence (AI) and machine learning (ML) applications, and metabolic surgery.

Download a free sample to assess the report’s scope and structure:

https://www.thebusinessresearchcompany.com/sample.aspx?id=13050&type=smp

What Are the Core Growth Drivers Propelling the Type 2 Diabetes Market Forward?

The growth of the market for type 2 diabetes is anticipated to be driven by escalating obesity and heart disease rates. Both obesity, which is a health condition marked by runaway body fat accumulation, and heart disease, which encompasses conditions impacting the heart and blood vessels, are expected to be primary drivers. Overweight individuals have a higher chance of developing insulin resistance which results in elevated blood sugar levels, leading to type 2 diabetes. Conversely, overly high blood sugar levels may damage blood vessels and nerves responsible for the heart and blood vessels, causing heart disease. As an example, the World Health Organization (WHO) stated in March 2024 that around one in eight people globally were having issues with obesity. This included 2.5 billion adults age 18 and above who were overweight and 890 million who were obese. Among adults, 43% were considered overweight and 16% obese. The number of overweight children below five had also risen to 37 million. Thus, increasing obesity and heart disease rates are the fuels for the growth of the type 2 diabetes market. The surge in the geriatric population is also projected to be a key factor contributing to type 2 diabetes market growth. The geriatric population includes individuals that are 65 and older who have a higher propensity for several diseases due to age and weakened immunity. As they age, the risk of encountering complications related to type 2 diabetes such as hypoglycemia, renal failure, and heart disease increases. These troubles can result in acute as well as chronic microvascular and cardiovascular complications. For instance, the World Health Organization forecasts that by 2030, one in every six people globally will be 60 years or older. The global population of individuals aged 60 and over will double to 2.1 billion by 2050. Moreover, between 2020 and 2050, the number of people who are 80 and above will rise by 426 million compared to current numbers. Therefore, the increase in geriatric population is contributing to the growth of the type 2 diabetes market.

What Segment Types Define the Type 2 Diabetes Market Structure?

The type 2 diabetes market covered in this report is segmented –

1) By Drug Class: Dipeptidyl Peptidase-4 (DPP-4) Inhibitors, Glucagon-Like Peptide-1 (GLP-1) Receptor Agonists, Thiazolidinediones, Alpha-Glucosidase Inhibitors, Sulfonylureas And Other Insulin Secretagogues, Biguanides, SodiumGlucose Cotransporter 2 Inhibitors, Other Drug Classes

2) By Application: Glycemic Control, Cardiovascular Safety, Hypoglycemia Avoidance, Other Applications

3) By End-User: Children, Adults

Subsegments:

1) By Dipeptidyl Peptidase-4 (DPP-4) Inhibitors: Sitagliptin, Saxagliptin, Linagliptin, Alogliptin

2) By Glucagon-Like Peptide-1 (GLP-1) Receptor Agonists: Liraglutide, Semaglutide, Dulaglutide, Exenatide

3) By Thiazolidinediones: Pioglitazone, Rosiglitazone

4) By Alpha-Glucosidase Inhibitors: Acarbose, Miglitol

5) By Sulfonylureas And Other Insulin Secretagogues: Glimepiride, Glipizide, Glyburide

6) By Biguanides: Metformin

7) By Sodium-Glucose Cotransporter 2 Inhibitors: Canagliflozin, Dapagliflozin, Empagliflozin

8) By Other Drug Classes: Amylin Analogues, Bile Acid Sequestrants, Dopamine Agonists

Request customized data on this market:

https://www.thebusinessresearchcompany.com/customise?id=13050&type=smp

Which Geographic Areas Hold the Strongest Growth Potential in the Type 2 Diabetes Market?

North America was the largest region in the type 2 diabetes market in 2024. Europe is expected to be the fastest-growing region in the forecast period. The regions covered in type 2 diabetes market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Which Emerging Trends that Are Influencing theType 2 Diabetes Industry Evolution?

Leading enterprises in the sector of type 2 diabetes are creating breakthrough products like Mounjaro to elevate the quality of safety and effectiveness for those battling diabetes. Medications like Mounjaro are engineered to bolster efficiency and safety and provide more convenience in dealing with diabetes compared to existing drugs. These revolutionary developments in diabetes drugs aim to enhance control over blood sugar levels, reduce potential side effects, and attend to associated health issues. For example, in May 2022, Eli Lilly and Co., an American pharmaceutical entity, secured the greenlight from the U.S. Food and Drug Administration, a U.S government agency, for the usage of Mounjaro (tripeptide) injection to augment blood sugar control in grown-ups with type 2 diabetes, paired with diet and exercise. Tirzepatide, a novel and dual-targeted remedy for type 2 diabetes, is a weekly injection that works on two blood sugar-regulating hormones- glucagon-like peptide 1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP). While GLP-1 initiates the increase in insulin production and curbs glucagon production, GIP helps in maximising insulin production. As such, Tirzepatide serves as a hopeful new therapy for individuals with type 2 diabetes, even those who haven’t seen any positive effects from other treatments.

View the full report here:

https://www.thebusinessresearchcompany.com/report/type-2-diabetes-global-market-report

What Is the Definition of the Type 2 Diabetes Market?

Type 2 diabetes is a chronic metabolic disorder characterized by elevated blood sugar levels due to insulin resistance and inadequate insulin production. The development of Type 2 diabetes is influenced by a combination of genetic, lifestyle and environmental factors. Dietary and pharmaceutical adjustments can manage type 2 diabetes by lowering weight, eating a healthy diet and exercising consistently.

Purchase the full report and get a swift delivery:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=13050

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model